Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 24 | GMDAQ Gamida Cell | Ordinary Shares | Grant | Acquire A | No | No | 0 | 200,000 | 0.00 | 232,300 |
19 Oct 23 | GMDAQ Gamida Cell | Ordinary Shares | Grant | Acquire A | No | No | 0 | 28,300 | 0.00 | 32,300 |
19 Oct 23 | GMDAQ Gamida Cell | Share Option Ordinary Shares | Grant | Acquire A | No | No | 1.59 | 56,600 | 89.99 k | 56,600 |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 47,824 | 0.00 | 0 | |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 27,954 | 0.00 | 47,824 | |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.3501 | 71,736 | 25.11 k | 0 |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.01 | 34,663 | 35.01 k | 0 |